Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease
暂无分享,去创建一个
H. Stefánsson | D. Rujescu | A. Ingason | S. Steinberg | I. Giegling | S. Djurovic | A. Kong | O. Andreassen | K. Stefánsson | A. Levey | L. Westlye | H. Helgason | P. Sulem | O. Magnusson | H. Soininen | A. Witoelar | H. Hampel | D. Aarsland | T. Fladby | S. A. Gudjonsson | M. Hiltunen | S. Helisalmi | I. S. Almdahl | Fred Andersen | S. Bjornsson | Anne Brækhus | P. Jonsson | A. Rongve | I. Saltvedt | S. Sando | G. Selbæk | J. Snaedal | E. Stordal | I. Ulstein | L. White | J. Lah | N. Bogdanovic | K. Engedal | T. Jónsson | G. Knudsen | U. Unnsteinsdottir | Hrefna S Johannsdottir | Ina Selseth Fred Nenad Anne Knut Arvid Ingvild Eystein Almdahl Andersen Bogdanovic Brækhus Engedal R | Aree Witoelar | Thorlákur Jónsson | Hrefna Johannsdottir | U. Unnsteinsdóttir | Sigurbjorn Bjornsson
[1] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[2] A. Singleton,et al. TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.
[3] A. Hofman,et al. Variant of TREM2 associated with the risk of Alzheimer's disease. , 2013, The New England journal of medicine.
[4] Ole A. Andreassen,et al. A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline , 2012, Nature.
[5] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[6] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[7] Manjit,et al. Neurology , 1912, NeuroImage.
[8] K. Moore,et al. Abca7 Null Mice Retain Normal Macrophage Phosphatidylcholine and Cholesterol Efflux Activity despite Alterations in Adipose Mass and Serum Cholesterol Levels* , 2005, Journal of Biological Chemistry.
[9] Marc Cruts,et al. Locus-Specific Mutation Databases for Neurodegenerative Brain Diseases , 2012, Human mutation.
[10] M. Pericak-Vance,et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[11] D. Wilkin,et al. Neuron , 2001, Brain Research.
[12] R. Rosenfeld. Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[13] R. Pearl. Biometrics , 1914, The American Naturalist.
[14] H. Neumann,et al. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2 , 2005, The Journal of experimental medicine.
[15] Nick C Fox,et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.
[16] P. Linsel-Nitschke,et al. ATP-binding cassette transporter A7 enhances phagocytosis of apoptotic cells and associated ERK signaling in macrophages , 2006, The Journal of cell biology.
[17] 김삼묘,et al. “Bioinformatics” 특집을 내면서 , 2000 .
[18] A. D. Roses,et al. Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .
[19] C. Weickert,et al. Role of ATP‐binding cassette transporters in brain lipid transport and neurological disease , 2008, Journal of neurochemistry.
[20] Margaret A. Pericak-Vance,et al. Novel late-onset Alzheimer disease loci variants associate with brain gene expression , 2012, Neurology.
[21] Pall I. Olason,et al. Detection of sharing by descent, long-range phasing and haplotype imputation , 2008, Nature Genetics.
[22] P. Magnus,et al. Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa). , 2006, International journal of epidemiology.
[23] S. Yokoyama,et al. Human ABCA7 Supports Apolipoprotein-mediated Release of Cellular Cholesterol and Phospholipid to Generate High Density Lipoprotein* , 2004, Journal of Biological Chemistry.
[24] S. Yokoyama,et al. ABCA7 expression is regulated by cellular cholesterol through the SREBP2 pathway and associated with phagocytosis Published, JLR Papers in Press, June 20, 2006. , 2006, Journal of Lipid Research.
[25] D. Elliott,et al. Deletion of Abca7 Increases Cerebral Amyloid-β Accumulation in the J20 Mouse Model of Alzheimer's Disease , 2013, The Journal of Neuroscience.
[26] Xihong Lin,et al. Rare-variant association testing for sequencing data with the sequence kernel association test. , 2011, American journal of human genetics.
[27] P. Linsel-Nitschke,et al. ATP-binding Cassette Transporter A7 (ABCA7) Binds Apolipoprotein A-I and Mediates Cellular Phospholipid but Not Cholesterol Efflux* , 2003, Journal of Biological Chemistry.
[28] Daniel F. Gudbjartsson,et al. Nonsense mutation in the LGR4 gene is associated with several human diseases and other traits , 2013, Nature.
[29] H. Soininen,et al. Elucidation of the BACE1 regulating factor GGA3 in Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.
[30] Bradley T. Hyman,et al. Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta , 2013, Neuron.
[31] Daniel Rios,et al. Bioinformatics Applications Note Databases and Ontologies Deriving the Consequences of Genomic Variants with the Ensembl Api and Snp Effect Predictor , 2022 .
[32] D. Fardo,et al. ABCA7 expression is associated with Alzheimer's disease polymorphism and disease status , 2013, Neuroscience Letters.
[33] K. Roeder,et al. Genomic Control for Association Studies , 1999, Biometrics.